Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs remifentanil for reducing bleeding in paranasal sinus surgery
IRCT20220222054094N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and remifentanil in intraoperative bleeding (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Intraoperative bleeding volume. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on IRCT20220222054094N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220222054094N1.